An unknown buyer agreed to acquire 11.96% stake in Oncolys BioPharma Inc. from HUNUS Inc. (KOSE:A014190) for KRW 15.1 billion on June 27, 2013. Upon closing, HUNUS will hold 0.71 million shares. Oncolys BioPharma Inc. reported total assets of ¥800 million (KRW 9,945.58 million), shareholders' equity of ¥472 million (KRW 5,867.89 million), net sales of ¥396 million (KRW 4,923.06 million), operating loss of ¥140 million (KRW 1,740.48 million) and net loss of ¥102 million (KRW 1,268.06 million) for the year ending December 31, 2012.

The Board of Directors of Hunus resolved to undertake the transaction on June 27, 2013. The transaction is expected to close on July 5, 2013. The conversion for financials was done through www.oanda.com as at December 31, 2012.